Clindamycin Hydrochloride Capsule shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting 2026-02-25 · last update 2026-02-25
Manufacturers: Pfizer Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 02/25/2026 Updated 02/25/2026 Discontinued 02/25/2026 |
| Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 02/25/2026 Updated 02/25/2026 Discontinued 02/25/2026 |
| Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 02/25/2026 Updated 02/25/2026 Discontinued 02/25/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)